SPX’s regulatory roles in energy balance, as well as glucose and lipid metabolism, facilitate the development of innovative therapeutic approaches for treating chronic conditions such as obesity, diabetes, and cardiovascular diseases [30]. The gene discussed is SPX; the disease is obesity due to melanocortin 4 receptor deficiency.